Affirmative
AI saves lives at scale
An AI system that correctly diagnoses diabetic retinopathy in a rural clinic with no ophthalmologist is not replacing care; it is creating care that did not exist. Requiring physician sign-off eliminates the only advantage.
Read the affirmative case
- FDA-approved AI diagnostic tools already operate autonomously for specific conditions. IDx-DR reads retinal scans without any physician review, and the FDA's 2018 authorization was grounded in clinical evidence that autonomous AI was safer than the available alternative, which was no screening at all. Extending this model to other well-validated conditions follows the same regulatory logic that has already been applied.
- Studies in Nature Medicine and The Lancet have shown AI systems outperforming average board-certified specialists in targeted tasks: detecting breast cancer on mammograms, identifying diabetic eye disease, and classifying skin lesions. The relevant comparison is not AI versus the best physician in the world; it is AI versus the physician who is actually available, which in most of the world means no physician at all.
- Requiring physician sign-off on every AI recommendation reinstates the scarcity bottleneck that AI was built to eliminate. If an AI correctly diagnoses tuberculosis from a chest X-ray in seconds, mandating that a physician review every result before treatment delays care by hours in contexts where physician time is the binding constraint, not diagnostic accuracy.
